Comparative Effect of Graston Technique and Petrissage Technique on Tight Trapezius Muscles in Young Adults

May 25, 2024 updated by: Muhammad Naveed Babur, Superior University
This research aims to contribute valuable insights into the potential benefits of incorporating the portable wedge device into preventive or therapeutic interventions for calf-related musculoskeletal issues. By combining economical, ergonomic principles and user-friendly features, the proposed device offers individuals a convenient and efficient means to enhance their calf flexibility, ultimately mitigating strain and reducing spasms.

Study Overview

Status

Active, not recruiting

Detailed Description

Developing and successfully integrating a portable wedge device could mark a significant breakthrough in preventive and rehabilitative care for musculoskeletal problems associated with the calf region. This innovative device can enhance the overall well-being and musculoskeletal health of individuals suffering from such issues, providing a more effective and convenient treatment solution.

Study Type

Interventional

Enrollment (Actual)

46

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Punjab
      • Lahore, Punjab, Pakistan
        • Faqraj Sharif Hospital (Trust) Physiotherapy and Orthopedic Department and Orian ABA Pakistan (Physiotherapy Department)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Male and female patients diagnosed with Trapezius tightness
  • Age above 18-30
  • Presence of active trigger points in the upper trapezius muscle
  • Participants who are volunteer for the study
  • Patients who suffer from shoulder pain and stiffness due to bad posture

Exclusion Criteria:

  • History of whiplash injury
  • History of head, neck, cervical spine or shoulder surgery
  • History of cervical radiculopathy
  • Diagnosed fibromyalgia and myopathy
  • History of cancer
  • Pregnancy Myofascial therapy within the past month
  • Contraindication of dry needling and instrument-assisted soft tissue mobilization technique

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Petrissage
The calf muscles will receive a firm, deep-circulation massage with fingertip pressure
Experimental: Graston Technique
The calf muscles will receive a firm, deep-circulation massage with fingertip pressure

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Numeric Pain Rating Scale (NPRS)
Time Frame: 12 Months
A pain scale is a method used to quantify the level of discomfort a person is experiencing. It assesses a person's level of pain intensity on a scale from 0 to 10. The scale rates a person's level of discomfort at a particular moment and goes from '0', indicating no pain, to '10,' representing the worst pain imaginable. This simple yet efficient method is widely used to help healthcare professionals evaluate and treat pain.
12 Months
Neck disability index (NDI)
Time Frame: 12 months
To evaluate a patient's functional status, ten questions are asked about their condition, including pain, personal care, lifting, reading, headaches, focus, job, driving, sleeping, and recreation. Each category is scored from 0 to 5, where 0 indicates "No pain" and 5 indicates "Worst imaginable pain." The score can be multiplied by two to get a percentage score, with a maximum score of fifty.
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2023

Primary Completion (Actual)

May 1, 2024

Study Completion (Estimated)

October 29, 2024

Study Registration Dates

First Submitted

May 25, 2024

First Submitted That Met QC Criteria

May 25, 2024

First Posted (Actual)

May 31, 2024

Study Record Updates

Last Update Posted (Actual)

May 31, 2024

Last Update Submitted That Met QC Criteria

May 25, 2024

Last Verified

May 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • MSRSW/Batch-Fall22/717

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe